Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $7.41B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 24.6B 1.95B Sep/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Ultragenyx Pharmaceutical USD 1.36B 1.93B Nov/2026
Vertex Pharmaceuticals USD 142.88B 10.37B Nov/2026
Xencor USD 1.19B 301M Jun/2026